156 related articles for article (PubMed ID: 36932995)
1. Monitoring the Reversibility of GPCR Signaling by Combining Photochromic Ligands with Label-free Impedance Analysis.
Wirth U; Erl J; Azzam S; Höring C; Skiba M; Singh R; Hochmuth K; Keller M; Wegener J; König B
Angew Chem Int Ed Engl; 2023 May; 62(21):e202215547. PubMed ID: 36932995
[TBL] [Abstract][Full Text] [Related]
2. Label-free impedance-based whole cell assay to study GPCR pharmacology.
Doornbos MLJ; Heitman LH
Methods Cell Biol; 2019; 149():179-194. PubMed ID: 30616818
[TBL] [Abstract][Full Text] [Related]
3. Label-free impedance measurements to unravel biomolecular interactions involved in G protein-coupled receptor signaling.
Skiba M; Stolwijk JA; Wegener J
Methods Cell Biol; 2022; 169():221-236. PubMed ID: 35623703
[TBL] [Abstract][Full Text] [Related]
4. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors.
Yu N; Atienza JM; Bernard J; Blanc S; Zhu J; Wang X; Xu X; Abassi YA
Anal Chem; 2006 Jan; 78(1):35-43. PubMed ID: 16383308
[TBL] [Abstract][Full Text] [Related]
5. Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool.
Doijen J; Van Loy T; Landuyt B; Luyten W; Schols D; Schoofs L
Biosens Bioelectron; 2019 Jul; 137():33-44. PubMed ID: 31077988
[TBL] [Abstract][Full Text] [Related]
6. Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays.
Stolwijk JA; Mildner AK; Kade C; Skiba M; Bernhardt G; Buschauer A; Huebner H; Gmeiner P; Wegener J
J Vis Exp; 2020 Feb; (156):. PubMed ID: 32150162
[TBL] [Abstract][Full Text] [Related]
7. A label-free impedance-based whole cell assay revealed a new G protein-coupled receptor ligand for mouse microglial cell migration.
Fukano Y; Okino N; Furuya S; Ito M
Biochem Biophys Res Commun; 2016 Sep; 478(2):624-30. PubMed ID: 27480930
[TBL] [Abstract][Full Text] [Related]
8. Comparing label-free biosensors for pharmacological screening with cell-based functional assays.
Peters MF; Vaillancourt F; Heroux M; Valiquette M; Scott CW
Assay Drug Dev Technol; 2010 Apr; 8(2):219-27. PubMed ID: 20085460
[TBL] [Abstract][Full Text] [Related]
9. Impedance responses reveal β₂-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles.
Stallaert W; Dorn JF; van der Westhuizen E; Audet M; Bouvier M
PLoS One; 2012; 7(1):e29420. PubMed ID: 22242170
[TBL] [Abstract][Full Text] [Related]
10. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.
Peters MF; Scott CW
J Biomol Screen; 2009 Mar; 14(3):246-55. PubMed ID: 19211780
[TBL] [Abstract][Full Text] [Related]
11. Strategies and considerations of G-protein-coupled receptor photopharmacology.
Berizzi AE; Goudet C
Adv Pharmacol; 2020; 88():143-172. PubMed ID: 32416866
[TBL] [Abstract][Full Text] [Related]
12. Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
Stoeber M; Jullié D; Li J; Chakraborty S; Majumdar S; Lambert NA; Manglik A; von Zastrow M
Elife; 2020 Feb; 9():. PubMed ID: 32096468
[TBL] [Abstract][Full Text] [Related]
13. Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands.
Goetzl EJ
FASEB J; 2007 Mar; 21(3):638-42. PubMed ID: 17194692
[TBL] [Abstract][Full Text] [Related]
14. Increasing the throughput of label-free cell assays to study the activation of G-protein-coupled receptors by using a serial agonist exposure protocol.
Stolwijk JA; Skiba M; Kade C; Bernhardt G; Buschauer A; Hübner H; Gmeiner P; Wegener J
Integr Biol (Camb); 2019 Mar; 11(3):99-108. PubMed ID: 31083709
[TBL] [Abstract][Full Text] [Related]
15. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
Seyedabadi M; Ghahremani MH; Albert PR
Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
[TBL] [Abstract][Full Text] [Related]
16. Luciferase reporter assay for unlocking ligand-mediated signaling of GPCRs.
Unal H
Methods Cell Biol; 2019; 149():19-30. PubMed ID: 30616819
[TBL] [Abstract][Full Text] [Related]
17. Real-time assay for GPCRs.
Erickson B
Anal Chem; 2006 Jan; 78(1):12. PubMed ID: 16419327
[No Abstract] [Full Text] [Related]
18. Dynamic mass redistribution reveals diverging importance of PDZ-ligands for G protein-coupled receptor pharmacodynamics.
Camp ND; Lee KS; Cherry A; Wacker-Mhyre JL; Kountz TS; Park JM; Harris DA; Estrada M; Stewart A; Stella N; Wolf-Yadlin A; Hague C
Pharmacol Res; 2016 Mar; 105():13-21. PubMed ID: 26773201
[TBL] [Abstract][Full Text] [Related]
19. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
Laroche G; Giguère PM
Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
[TBL] [Abstract][Full Text] [Related]
20. Biophysical investigations of class A GPCRs.
Casiraghi M
Biochimie; 2023 Feb; 205():86-94. PubMed ID: 36220484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
